4 days ago - Catapult Group International .... Other LT Assets. 4.5 ..... SPP of shares in Catapult Group International
Technology - Others│Australia│Equity research│March 26, 2018
Catapult Group International Go early, go hard
ADD (no change) Current price: Target price: Previous target: Up/downside: Reuters: Bloomberg: Market cap:
A$1.18 A$1.76 A$2.02 49.3% CAT.AX CAT AU US$153.3m A$198.4m US$0.67m A$0.85m 191.4m 38.4%
Average daily turnover: Current shares o/s Free float: Key changes in this note FY19F EPS down by 333%. FY20F EPS down by 57%. FY21F EPS down by 28%. Price Close
Relative to S&P/ASX 200 (RHS)
2.40
112
1.90
87
1.40
62
0.90 8
37
6
Vol m
4 2 Mar-17
Jun-17
Sep-17
Dec-17
■ Catapult yesterday announced an A$25m equity raising, with the funds to be used to expand the long run rate of revenue growth through higher investment in sales and marketing and technology.
■ The accelerated level of investment will result in higher operating losses, especially in FY19 and FY20, but should lead to a more robust business in the long run.
■ We have reduced our earnings forecasts and valuation. Our DCF valuation, which sets our price target, falls to A$1.76 (from A$2.02).
■ We maintain an ADD recommendation (high risk).
Funding for certainty Catapult’s greatly expanded FY19 and FY20 invest-for-growth plan will materially increase short-term losses. However, we expect the “go early, go hard” strategy Catapult unveiled today will minimise risk and increase certainty, making it possible to be on the front foot of sales opportunities and deprive competitors of oxygen. Without capital constraints, Catapult can chase growth without looking anxiously towards its next quarterly cash flow report. Assuming the new CEO’s plan of expanding international sales and service staff more than 30% pays off, revenue growth momentum should return to former levels.
Changes to forecasts, valuation The new investment spending plan has had a detrimental impact on our earnings forecasts, mostly in FY19 and FY20. Our EBITDA forecasts fall by A$13.6m in FY19 and by A$7m in FY20, but the pain diminishes thereafter. Our DCF valuation – which sets our price target – falls to A$1.76 per share (from A$2.02 per share).
Risks and catalysts
Source: Bloomberg
T (61) 3 9947 4182
Risks to Catapult’s near-term revenues and share price include: 1) failure to secure major league-wide deals; 2) new team-based contract signings fall short of expectations; 3) further operating cost blow-outs; and 4) irrational competitor behaviour or a major league-wide deal by a competitor with negative implications for Catapult. Potential nearterm re-rating catalysts for Catapult include: 1) winning one or more significant leaguewide subscription deals; 2) better-than-expected team-based subscription sales; 3) better-than-expected cost controls; and 4) loss of a major client by a close rival.
E
[email protected]
Investment view
Price performance Absolute (%) Relative (%)
1M -10.3 -6.8
Ivor RIES
3M 12M -27.2 -50.4 -22.6 -51.8
Catapult’s closing share price prior to yesterday’s deal was substantially below our revised valuation and we therefore retain an ADD recommendation. As Catapult has not yet become self-sustaining from a cash flow view, the stock is high risk.
Financial Summary Revenue (A$m) Operating EBITDA (A$m) Net Profit (A$m) Normalised EPS (A$) Normalised EPS Growth FD Normalised P/E (x) DPS (A$) Dividend Yield EV/EBITDA (x) P/FCFE (x) Net Gearing P/BV (x) ROE % Change In Normalised EPS Estimates Normalised EPS/consensus EPS (x)
Jun-17A 60.8 2.99 -13.58 (0.018) (36%) NA 0% 62 NA (11.2%) 1.73 (4.9%)
Jun-18F 76.1 0.19 -18.09 (0.041) 124% NA 0% 1,023 NA (22.3%) 1.78 (6.6%) 12% 0.63
Jun-19F 100.7 -1.84 -18.55 (0.053) 28% NA 0% NA NA (12.8%) 2.03 (8.5%) (333%) 5.89
Jun-20F 130.6 17.57 -0.22 0.040 29.79 0% 12 40.16 (17.4%) 1.98 6.7% (57%) 0.86
Jun-21F 159.4 32.50 10.79 0.097 145% 12.15 0% 6 11.70 (30.1%) 1.73 15.2% (28%)
SOURCE: MORGANS, COMPANY REPORTS
IMPORTANT DISCLOSURES REGARDING COMPANIES THAT ARE THE SUBJECT OF THIS REPORT AND AN EXPLANATION OF RECOMMENDATIONS CAN BE FOUND AT THE END OF THIS DOCUMENT. MORGANS FINANCIAL LIMITED (ABN 49 010 669 726) AFSL 235410 - A PARTICIPANT OF ASX GROUP
Powered by EFA
Technology - Others│Australia│Equity research│March 26, 2018
Figure 1: Financial summary ASX Code Issued shares (m) Market Capital (A$m)
CAT Share Price A$ 191.4 Recommendation: 226 Valuation: Price Target: TSR:
Key Financials Reported NPAT Normalised NPAT EPS - reported EPS - normalised EPS Growth EPS - diluted Dividend per share Payout Ratio Franking
Pricing Multiples Normalised PER Diluted PER Market PER (*) PER Relative EV/EBITDA EV/EBIT Price/Book Yield
2017 -13.6 -3.1 -8.1 -1.8 0 0% -
2017 -
2018F -18.1 -7.9 -9.5 -4.1 -124% -4.4 0 0% -
2018 -12 -12 18.4 1023.0 -14 2.0 -
2019F -18.5 -10.1 -9.7 -5.3 -28% -5.3 0 0% -
1.18 ADD 1.76 1.76 49.3%
2020F -0.2 7.6 -0.1 4.0 -175% 4.0 0 0% -
Normalised P&L Divisional Revenues (A$m) Elite wearables XOS Prosumer AMS Tactical Other Total Revenues
2021F 10.8 18.6 5.6 9.7 145% 9.7 0 0% -
2019 -12 -12 17.2 -71% -115.0 -10 1.8 -
2020 -1034 -1034 16.0 -6462% 11.7 -211.7 2.0 -
2021 21 21 14.9 141% 5.7 0.0 0.0 -
Valuation Risk Free Rate Equity Risk Premium Beta Cost of Equity Gearing Ratio Cost of Debt WACC Terminal Growth Rate (Y5) DCF Valuation Value Per Share
2017
2018
2019
2020
2021
250% 13% -
25% -94% -
32% -28% -36%
30% #N/A -32%
22% 100% 95%
5% -18% -23%
0% -19% -21%
-2% -19% -18%
13% -1% 0%
20% 8% 8%
-5% -3% -4%
-7% -5% -3%
-9% -6% -6%
7% 4% 4%
14% 10% 11%
-
-
-
-
-
% % % % % % % $m $/shr
6.0% 6.0% 1.15 12.9% 0% 4.0% 12.0% 7.5% 337 1.76
2017
2018F
2019F
2020F
2021F
17.3
27.3 33.3 0.1
18.7
60.8
33.7 37.3 2.0 2.2 0.1 1.0 76.1
45.1 42.4 7.3 3.8 1.6 2.0 101
56.9 44.2 16.1 4.8 3.8 2.0 131
71.4 47.9 21.6 5.8 6.4 2.0 159
-4.4
-4.4
2.5 9.0 -5.9 0.0 0.0 -2.8 3.0
5.4 10.3 -3.4 0.8 -1.9 -10.0 0.2
6.0 12.1 -8.6 1.9 -0.9 -9.8 -1.8
12.5 12.7 1.4 2.7 0.7 -10.5 17.6
20.5 14.0 5.3 3.4 2.5 -11.2 32.5
-1.8 -6.2 0.0 0 0 -8.6 2.8 -5.9 2.3 -3.6
-13.6 -10.6 0.0 0 0 -14.0 0.5 -13.6 10.5 -3.1
-14.7 -14.5 0.0 0 0 -16.1 -2.0 -18.1 10.2 -7.9
-17.4 -19.2 0.7 0 0 -18.5 0.0 -18.5 8.4 -10.1
-18.6 -1.0 0.8 0 0 -0.2 0.0 -0.2 7.8 7.6
-20.1 12.3 1.1 0 0 13.5 -2.7 10.8 7.8 18.6
Some corporate costs are included in the Elite Wearables unit. Balance Sheet 2016 2017 2018 2019 2020 Cash 3.6 16.7 28.3 14.3 19.9 Other ST Assets 12.3 32.2 18.5 20.2 22.3 PPE 4.2 7.7 9.0 11.2 13.9 Intangibles 9.9 104.5 118.8 116.4 111.9 Other LT Assets 4.5 10.4 12.1 12.1 12.1 Total Assets 30 161 175 162 168 Borrowings 0.0 0.7 0.0 0.0 0.0 Other Liabilities 18.2 45.8 48.2 50.9 54.0 Total Liabilities 18.2 46.5 48.3 51.0 54.1 Net Assets 11.9 114.8 126.5 111.4 114.3 Minorities 0 0 0 0 0
2021 39.2 24.8 17.1 107.3 12.1 189 0.0 58.3 58.3 130.4 0
Cash Flows EBITDA Interest paid Interest received Tax Paid Other Net Operating Cash Flow Capex Other investing cash flow Investing Cash Flow Financing Cash Flow Total Cash Flows
2021 32.5 0.0 1.1 -2.7 0.0 35.8 -16.5 0.0 -16.5 0.0 19.3
Divisional EBITDA (A$m) Elite wearables XOS Prosumer AMS Tactical Other Total EBITDA Deprec. & Amort. EBIT Finance Costs - net Minorities Associates PBT Tax NPAT - reported Adjustments NPAT - adjusted
(*) Market PER = ASX 100 Industrials PER
Key Ratios Growth Revenue Growth EBITDA Growth EBIT Growth Margins EBITDA/Sales EBIT/Sales Pre-Tax/Sales Efficiency ROE ROA ROIC Leverage Net Debt/Debt+Equity EBITDA/Interest Cover Net Debt/EBITDA Catapult has no net debt.
2016
Company Contacts Catapult International 1 Aurora Lane Docklands Victoria 3008 Australia Telephone: +61 3 9095 8410
2016 -4.4 0.0 0.0 0.0 0.7 -4.3 -6.5 1.0 -5.5 5.7 -2.0
2017 3.0 -2.8 0.1 0.0 0.1 -10.5 -10.7 -82.2 -92.9 115.4 13.6
2018 0.2 -0.1 0.1 0.0 0.0 7.4 -13.0 -1.5 -14.5 20.8 11.7
Chairman Chief Executive CFO
2019 -1.8 0.0 0.7 0.0 0.0 1.0 -15.0 0.0 -15.0 0.0 -14.0
2020 17.6 0.0 0.8 0.0 0.0 20.5 -14.9 0.0 -14.9 0.0 5.6
Dr Adir Shiffman Mr Joe Powell Mr Mark Hall
www.catapultsports.com.
SOURCE: MORGANS RESEARCH, COMPANY
2
Technology - Others│Australia│Equity research│March 26, 2018
Pedal to the metal New funds give best chance of success Catapult has announced plans to raise A$25m in additional capital in order to accelerate the rate of investment in sales and marketing and new technologies. The new funds will be invested in Elite wearables sales and marketing (A$9m), the rollout and expansion of the Prosumer product range (A$9m), development of the new Tactical Coaching tool suite (A$3.0m) and investment in the core technology stack (A$2.8m). The company said that no new equity funding should be required before the company becomes cash flow self-sustaining. “Based on the company’s current strategy and supported by its three-year plan, management does not anticipate requiring additional equity funding before becoming cash flow positive,” the directors said. The following table sets out the proposed usage of the new funds. Figure 2: Catapult uses of funds Uses Of Funds Elite sales and marketing
A$m 9.0
Prosumer roll-out and expansion
9.0
Tactical product development
3.0
Investment in technology stack
2.8
Transaction fees
1.2
Total Uses
25.0 SOURCES: CATAPULT
Elite Wearables sales and marketing Catalyst plans to spend roughly A$4.5m a year over and above the “business as usual” case over FY19 and FY20 in adding new sales and technical customer service staff, many in geographic areas where Catapult does not currently have permanent offices. This investment will lift the total full-time equivalent sales force to about 90 people. The new investment in sales and marketing will be closely monitored by the CEO and CFO to make sure that it delivers the required level of sales momentum. Our revised forecasts only assume a modest uplift in revenues from this initiative in Elite Wearables from FY20 onwards.
Prosumer roll-out Catalyst plans to spend roughly A$9m over 12-18 months on heightened marketing, logistics and customer service associated with the launch of the new Prosumer device in FY19. We assume that A$7m of this is treated as an operating expense and a further A$2m is working capital (not expensed). Virtually all of the expense impact will fall in FY19.
Technology investment Catalyst plans to spend A$3.0m on development of its new coaching Tactical analytics tools and A$2.8m on improving the performance of its overall technology stack over 12-18 months. These costs will be capitalised and amortised, as usual for core technologies, over four years.
Cash flow break-even Catalyst’s fund raising document implies that the company does not anticipate becoming cash flow break-even before FY21. In our view management’s forecast on this issue is overly cautious, as for this to occur the rate of sales momentum would need to slow materially from our current projections. Our forecasts assume a small (A$5m) free cash flow surplus to be generated in FY20.
3
Technology - Others│Australia│Equity research│March 26, 2018
Impact on earnings forecasts Catalyst has tended to expense most of its new business and technology development costs, rather than capitalise such costs and amortise them over time. Thus some capital costs are bundled with normal operating expenses, making the underlying operating performance of each business difficult to estimate. The decision to accelerate investment spending has thus had a detrimental impact on our earnings forecasts. Changes to our forecasts are shown in the following table. Key changes to our forecasting assumptions were:
An increase in marketing and customer support costs (expensed) in Elite Wearables of A$4.5m a year, commencing in July 2019. We assume no incremental revenue uplift from this sales and marketing cost in FY19 and a steadily rising revenue uplift from FY20. We assume the elevated level of sales and support spending continues in perpetuity.
An additional outlay (expensed) for Prosumer product marketing and logistics of A$7m in FY19, with no incremental revenue uplift from this investment until the FY20 year.
Roughly A$2m of the A$9m earmarked to be invested in Prosumer is working capital and thus has no impact on reported earnings.
The A$3m targeted for Tactical product development and A$2.8m for investment in the core technology stack will be capitalised and amortised over four years.
Overall operating costs are higher than our previous forecast. Thus while terminal year revenues are revised upwards, our terminal year EBITDA is essentially unchanged.
Figure 3: Changes to profit forecasts YE June Revenues Former Revised Ebitda Former Revised NPAT - reported Former Revised NPAT - adjusted Former Revised EPS - underlying Former Revised EPS - reported Former Revised
2018
2019
2020
2021
2022
$m $m
76.1 76.1
100.7 100.7
125.8 130.6
148.4 159.4
167.6 185.1
$m $m
0.2 0.2
11.8 -1.8
24.6 17.6
36.2 32.5
45.8 45.6
$m $m
-18.1 -18.1
-4.6 -18.5
7.8 -0.2
14.8 10.8
23.0 21.9
$m $m
-7.9 -7.9
3.8 -10.1
15.6 7.6
22.6 18.6
25.9 24.8
$m $m
-4.7 -4.1
2.3 -5.3
9.3 4.0
12.5 8.9
14.9 12.5
¢ ¢
-10.8 -9.5
-2.7 -9.7
4.6 -0.1
8.8 5.6
13.7 11.4
SOURCES: MORGANS ESTIMATES
Impact on valuation and price target Our 12-month price target is set by our discounted cash flow (DCF) valuation. Due to the impact of higher investment spending highlighted above, and the dilution caused by the capital raising, our discounted cash flow valuation has declined to A$1.76 per share (from A$2.02 per share). Risks to our valuation and price target being achieved are set out in the risks and catalysts section below.
4
Technology - Others│Australia│Equity research│March 26, 2018
Figure 4: Discounted cash flow valuation Year ended 30 June A$m EBIT D&A Ebitda Capex (SIB) WC Change Interest Tax Free Cash Flow Other adjustments Free Cash Flow
2018 2019 2020 2021 2022 (14) 15 0 -13 0 0 -2 (15) 3 (12)
(19) 17 (2) -15 0 0 0 (17) 2 (15)
(1) 19 18 -15 0 1 0 3 2 5
12 20 32 -17 0 1 0 17 2 19
29 17 46 -18 0 2 -7 22 2 24
Discount Factor 1.00 NPV of Free Cash Flow -12 NPV of Terminal Value NPV Ancillary revenues option Executive share plan dilution Total Present Value Shares Out NPV/Share
0.89 -13
0.80 4
0.71 14
0.64 15 337 336 30 -29 337 191 1.76
Modelling Assumptions Risk Free Rate Equity Risk Premium Company Beta Cost of Equity Debt % Cost of Debt Tax Rate WACC Long Term growth rate Implied TV Multiple Discounted Terminal Value NPV $
6.0% 6.0% 1.2 12.9% 0% 4.0% 30% 12.0% 7.5% 22.2 337 336
SOURCES: MORGANS ESTIMATES
Risks and catalysts Risks to Catapult’s near-term revenues and share price include: 1) failure to secure major league-wide deals; 2) new team-based contract signings fall short of expectations; 3) further operating cost blow-outs; and 4) irrational competitor behaviour or a major league-wide deal by a competitor with negative implications for Catapult. Potential near-term re-rating catalysts for Catapult include: 1) winning one or more significant league-wide subscription deals; 2) better-than-expected team-based subscription sales; 3) better- than-expected cost controls; and 4) loss of a major client by a close rival.
Investment view Catapult’s closing share price yesterday trades substantially below our revised valuation and we therefore retain an ADD recommendation. As Catapult has not yet become self-sustaining from a cash flow view, the stock is high risk.
5
Technology - Others│Australia│Equity research│March 26, 2018
Queensland Brisbane
New South Wales +61 7 3334 4888
Stockbroking, Corporate Advice, Wealth Management
Sydney
Victoria +61 2 9043 7900
Stockbroking, Corporate Advice, Wealth Management
Melbourne
Western Australia +61 3 9947 4111
Stockbroking, Corporate Advice, Wealth Management
West Perth
+61 8 6160 8700
Stockbroking, Corporate Advice, Wealth Management
Brisbane: Edward St
+61 7 3121 5677
Armidale
+61 2 6770 3300
Brighton
+61 3 9519 3555
Perth
Brisbane: Tynan Partners
+61 7 3152 0600
Ballina Balmain
+61 2 6686 4144 +61 2 8755 3333
Camberwell Domain
+61 3 9813 2945 +61 3 9066 3200
+61 8 6462 1999
South SouthAustralia Australia
Brisbane: North Quay
+61 7 3245 5466
Bowral
+61 2 4851 5555
Geelong
+61 3 5222 5128
Adelaide
+61 8 8464 5000
Bundaberg
+61 7 4153 1050
Chatswood
+61 2 8116 1700
Richmond
+61 3 9916 4000
Norwood
+61 8 8461 2800
Cairns
+61 7 4222 0555
Coffs Harbour
+61 2 6651 5700
South Yarra
+61 3 8762 1400
Caloundra
+61 7 5491 5422
Gosford
+61 2 4325 0884
Southbank
+61 3 9037 9444
Gladstone
+61 7 4972 8000
Hurstville
+61 2 8215 5079
Traralgon
+61 3 5176 6055
Gold Coast
+61 7 5581 5777
Merimbula
+61 2 6495 2869
Warrnambool
+61 3 5559 1500
Ipswich/Springfield
+61 7 3202 3995
Mona Vale
+61 2 9998 4200
Kedron
+61 7 3350 9000
Neutral Bay
+61 2 8969 7500
Australian Capital Territory
Mackay
+61 7 4957 3033
Newcastle
+61 2 4926 4044
Canberra
Milton
+61 7 3114 8600
Orange
+61 2 6361 9166
Noosa
+61 7 5449 9511
Port Macquarie
+61 2 6583 1735
Northern Territory
Redcliffe
+61 7 3897 3999
Scone
+61 2 6544 3144
Darwin
Rockhampton
+61 7 4922 5855
Sydney: Level 7
+61 2 8216 5111
Spring Hill
+61 7 3833 9333
Currency House
Sunshine Coast Toowoomba
+61 7 5479 2757 +61 7 4639 1277
Sydney: Grosvenor Place
+61 2 8215 5000
Townsville
+61 7 4725 5787
Sydney Reynolds
+61 2 9373 4452
Securities Wollongong
+61 2 4227 3022
+61 2 6232 4999
+61 8 8981 9555
Tasmania Hobart
+61 3 6236 9000
Disclaimer The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual’s relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so. Those acting upon such information without advice do so entirely at their own risk. This report was prepared as private communication to clients of Morgans and is not intended for public circulation, publication or for use by any third party. The contents of this report may not be reproduced in whole or in part without the prior written consent of Morgans. While this report is based on information from sources which Morgans believes are reliable, its accuracy and completeness cannot be guaranteed. Any opinions expressed reflect Morgans judgement at this date and are subject to change. Morgans is under no obligation to provide revised assessments in the event of changed circumstances. This report does not constitute an offer or invitation to purchase any securities and should not be relied upon in connection with any contract or commitment whatsoever.
Disclosure of interest Morgans may from time to time hold an interest in any security referred to in this report and may, as principal or agent, sell such interests. Morgans may previously have acted as manager or co-manager of a public offering of any such securities. Morgans affiliates may provide or have provided banking services or corporate finance to the companies referred to in the report. The knowledge of affiliates concerning such services may not be reflected in this report. Morgans advises that it may earn brokerage, commissions, fees or other benefits and advantages, direct or indirect, in connection with the making of a recommendation or a dealing by a client in these securities. Some or all of Morgans Authorised Representatives may be remunerated wholly or partly by way of commission.
Regulatory disclosures Analyst owns shares in the following mentioned company(ies): Morgans Corporate Limited was a joint lead manager to the placement & SPP of shares in Catapult Group International Limited and received fees in this regard.
Recommendation structure For a full explanation of the recommendation structure, refer to our website at http://www.morgans.com.au/research_disclaimer
Research team For analyst qualifications and experience, refer to our website at http://www.morgans.com.au/research-and-markets/our-research-team
Stocks under coverage For a full list of stocks under coverage, refer to our website at http://www.morgans.com.au/research-and-markets/company-analysis/ASX100-Companies-under-coverage and http://www.morgans.com.au/research-and-markets/company-analysis/EX-100-Companies-under-coverage
Stock selection process For an overview on the stock selection process, refer to our website at http://www.morgans.com.au/research-and-markets/company-analysis
www.morgans.com.au If you no longer wish to receive Morgans publications please contact your local Morgans branch or write to GPO Box 202 Brisbane QLD 4001 and include your account details. 12.12.17
6